Skip to main content

Table 1 Clinico-pathological characteristics of BC patients

From: Studying ferroptosis and iron metabolism pre- and post-radiotherapy treatment in breast cancer patients

 

BC patients group (n = 40)

Age (years)

 Mean ± SD

42.52 ± 11.58 years

 Range

(31–72) years

Histological grade

 I

3 (7.5%)

 II

31 (77.5%)

 III

6 (15%)

Axillary lymph node involvement

 Positive

19 (47.5%)

 Negative

21 (52.5%)

ER statusa

 Positive

34 (95%)

 Negative

6 (5%)

PR statusb

 Positive

37 (92.5%)

 Negative

3 (7.5%)

Her-2/neu expressionc

 Positive

0 (0%)

 Negative

40 (100%)

Tumor type

 IDCd

35 (87.5%)

 Other (ILCe and MCf and NSTg)

5 (12.5%)

Type of surgery

 Breast conservation

13 (32.5%)

 Mastectomy

27 (67.5%)

  1. aEstrogen receptor status
  2. bProgesterone receptor status
  3. cHuman epidermal growth factor receptor 2
  4. dInvasive ductal carcinoma
  5. eInvasive lobular carcinoma
  6. fMucinous carcinoma
  7. gInvasive carcinoma of no special type